MIN-SHU HSIEHBishop J.A.JULIA YU-FONG CHANG2022-01-082022-01-0820211875-9181https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098892105&doi=10.1016%2fj.path.2020.09.006&partnerID=40&md5=7bf3baf9c3655bb4a0f46e6df6ce480fhttps://scholars.lib.ntu.edu.tw/handle/123456789/591935Sialadenoma papilliferum (SP) is a rare, benign salivary gland neoplasm sharing similar histopathologic features and harboring the same genetic alterations, BRAF V600E or HRAS mutations, with syringocystadenoma papilliferum. SP most commonly occurs in theBRAF V600E mutation; Classic; HRAS Q61R mutation; Oncocytic; Sialadenoma papilliferum[SDGs]SDG3arginine; B Raf kinase; glutamic acid; glutamine; transcription factor Sox10; valine; B Raf kinase; BRAF protein, human; SOX10 protein, human; transcription factor Sox; clinical examination; differential diagnosis; gene mutation; histopathology; human; imreview10.1016/j.path.2020.09.006335262222-s2.0-85098892105